News | Treatment Planning | April 28, 2017

RayStation will allow U.K. hospital to implement adaptive therapy and significantly reduce planning time

Nottingham City Hospital Selects RayStation for Radiotherapy Treatment Planning

April 28, 2017 — Nottingham City Hospital in the United Kingdom has chosen RayStation as the new treatment planning system for its radiation therapy department. The department treats patients using Elekta linacs (linear accelerators) and an Accuray TomoTherapy system.

The Nottingham Radiotherapy Service is the specialist treatment center for Nottinghamshire and the East Midlands. The department has invested heavily in new technology and equipment in order to provide the best possible treatment for patients. Techniques offered include volumetric modulated arc therapy (VMAT), image-guided radiation therapy (IGRT), Papillon (contact brachytherapy) and selective internal radiation therapy (SIRT). Nottingham City Hospital is a stereotactic radiosurgery referral site and receives referrals from many hospitals across the region.

RayStation will replace separate software applications currently being used for virtual simulation, deformable registration, auto-segmentation and VMAT planning. The system will enable the hospital to implement adaptive therapy, and its fast computation speed will significantly reduce planning time.

Keith Langmack, head of radiotherapy physics at Nottingham City Hospital, said: “RayStation will consolidate the functionality of several different systems, giving us a smooth, integrated workflow. It can support both linacs and TomoTherapy systems and offers outstanding support for adaptive planning and automation. After a thorough evaluation of alternative systems, RayStation clearly had the edge.”

The City Hospital campus is part of Nottingham University Hospitals NHS Trust (NUH). Formed in 2006, it is now one of the largest acute trusts in England, employing 14,500 staff.  NUH provides services to over 2.5 million residents of Nottingham and its surrounding communities, as well as specialist services to a further 3-4 million people from neighboring counties. 

For more information: www.raysearchlabs.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now